NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
View on Grants.gov ↗ Sign in to save
- Type
- Grant
- Notice type
- G
- Agency
- National Institutes of Health
- Sub-agency
- HHS-NIH11
- Solicitation #
- PA-27-101
- Posted
- May 28, 2026
- Response due
- Apr 5, 2029
- Archive date
- Jun 4, 2029
- CFDA / Assistance listing
- 93.233,93.242,93.273,93.307,93.313,93.350,93.351,93.393,93.394,93.395,93.837,93.838,93.839,93.840,93.847,93.853,93.855,93.859,93.865,93.866,93.867
- Contact
- SEEDinfo@nih.gov
- Source
- Grants.gov
Description
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).